BIS (Quality Control) Amendment Order for the Hydrogenated Rice Bran Fatty Acids
CONFORMITY ASSESSMENT & REGULATORY COMPLIANCE
Dear Reader,
Important update regarding Indian Standard applicable to all existing Licence holders/ New applicants/ manufacturers/ importers/ product sellers for the Hydrogenated Rice Bran Fatty Acids Amendment Order, 2024.
BIS (Quality Control) Amendment Order for the Hydrogenated Rice Bran Fatty Acids
OVERVIEW
The Ministry of Chemicals and Fertilizers has introduced the Hydrogenated Rice Bran Fatty Acids (Quality Control) Amendment Order, 2024, amending the Hydrogenated Rice Bran Fatty Acids (Quality Control) Order, 2022.
This amendment is scheduled to come into effect on October 24, 2024.
This order applies to goods or articles specified as Hydrogenated Rice Bran Fatty Acids, with an exemption for those intended for export.
To ensure compliance, products related to Hydrogenated Rice Bran Fatty Acids must conform to the corresponding Indian Standard IS 12361:1988 and bear the Standard Mark. Compliance necessitates obtaining a license from the Bureau of Indian Standards, following Scheme-I as specified in Schedule-II of the Bureau of Indian Standards (Conformity Assessment) Regulations, 2018.
The certifying and enforcing authority for products covered by this order, specifically Hydrogenated Rice Bran Fatty Acids, is the Bureau of Indian Standards.
Any individual found in contravention of the provisions of this order will be subject to penalties by the relevant Act.
Implementation Authority : Bureau of Indian Standards (Govt. of India)
ALSO READ: BIS CERTIFICATION FOR HYDROGENATED RICE BRAN FATTY ACIDS IS 12361:1988
CONCERNED AUTHORITIES
Bureau of Indian Standards Manak Bhawan 9, B.S. Zafar Marg, New Delhi - 110002
Tel: +91-11-23231903
Email: fad@bis.org.in
Implementation Dates: 24th October 2024
For any queries on this update, write us at info@alephindia.in or Call +91 9990136656
For more details visit: Aleph INDIA
Attachment: Standard Amendment Order issued by Bureau of Indian Standards
Disclaimer: The information provided in this update is intended for informational purposes only. Readers are requested to seek formal legal advice prior to acting upon any of the information provided herein.
© 2022, Aleph INDIA. All Rights Reserved
